BAYERCROP
Bayer Cropscience India Limited
Each stock's 10,000-path forecast, rendered as light.
Bayer Cropscience India Limited (BAYERCROP) Stock Analysis & Case Study
Is BAYERCROP a good buy? The data-driven verdict.
Bayer Cropscience India Limited (BAYERCROP) trades at ₹4,177,on the numbers it mixed signals, a Downstox Snapshot Score of 49/100.
On the numbers, Bayer Cropscience India Limited (BAYERCROP) mixed signals, a Downstox Snapshot Score of 49/100, weighing expensive at 381.0× earnings, ROE of 15.8%, a 57% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
BAYERCROP fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How BAYERCROP ranks against the 2,373 companies in our screener
- BAYERCROP's market cap of 18,773 Cr ranks in the 84th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- BAYERCROP's book value of ₹85 ranks in the 47th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- BAYERCROP's promoter holding of 71.4% ranks in the 78th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- BAYERCROP's 3-year profit (PAT) growth of -4.0% ranks in the 25th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- BAYERCROP's 3-year revenue growth of -4.0% ranks in the 17th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- BAYERCROP's debt-to-equity ratio of 0.34x is lower than 48% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is BAYERCROP overvalued? BAYERCROP P/E vs peers
BAYERCROP trades at 381.0× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
BAYERCROP share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of BAYERCROP history (0%/yr drift, 27%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| BAYERCROP 2027 | ₹3,093 | ₹4,384 | ₹6,212 | +5% |
| BAYERCROP 2028 | ₹2,789 | ₹4,600 | ₹7,586 | +10% |
| BAYERCROP 2029 | ₹2,602 | ₹4,827 | ₹8,957 | +16% |
| BAYERCROP 2030 | ₹2,523 | ₹5,066 | ₹10,171 | +21% |
| BAYERCROP 2031 | ₹2,435 | ₹5,316 | ₹11,606 | +27% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability BAYERCROP goes up, or doubles?
The bull case for BAYERCROP
- BAYERCROP's return on equity of 15.8% ranks in the 74th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- BAYERCROP's return on capital employed of 20.1% ranks in the 80th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- BAYERCROP's dividend yield of 3.6% ranks in the top 3% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹8,957.
The bear case & risks
- BAYERCROP's P/E of 381.0x is lower than 3% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A steep 49.4× price-to-book means most of the value is intangible/expectations, not assets on the books.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹2,602.
BAYERCROP volatility & expected range, how bumpy is the ride?
Over the last 9.8 years BAYERCROP compounded at 0%/year with annualized volatility of 27%. That volatility implies a 1-year 80% range of ₹3,093-₹6,212, the honest backbone behind any single price target.
BAYERCROP price forecast, the full 60-month probability fan
BAYERCROP price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds BAYERCROP hits common targets within the simulated horizon?
Full multi-horizon detail on the BAYERCROP price target & forecast page.
BAYERCROP Piotroski F-Score: 4/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. BAYERCROP scores 4/8, mixed financial health.
BAYERCROP MTF margin & leverage across 11 brokers
Margin Trading Facility lets you buy BAYERCROP with part of the capital. Lower margin % = higher leverage. Rates compared across 11 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 27.32% | 3.7× |
| Zerodha | 27.30% | 3.7× |
| Groww | 27.34% | 3.7× |
| DhanCHEAPEST | 27.30% | 3.7× |
| Kotak Neo | 30.03% | 3.3× |
| Paytm Money | 28.21% | 3.5× |
| Pocketful | 27.52% | 3.6× |
| Fyers | 27.78% | 3.6× |
| Anand Rathi | 27.30% | 3.7× |
| Bajaj Broking | 30.00% | 3.3× |
| Share India | 27.34% | 3.7× |
Compare every broker on the BAYERCROP MTF page.
About Bayer Cropscience India Limited: sector, index & market-cap context
Bayer Cropscience India Limited (BAYERCROP) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index, with a market capitalisation of ₹18,773 Cr. See more stocks on our screener.
How the BAYERCROP Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Bayer Cropscience India Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
BAYERCROP analysis, FAQs
Is Bayer Cropscience India Limited (BAYERCROP) a good buy?
On the numbers, Bayer Cropscience India Limited (BAYERCROP) mixed signals, a Downstox Snapshot Score of 49/100, weighing expensive at 381.0× earnings, ROE of 15.8%, a 57% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is BAYERCROP overvalued or undervalued?
BAYERCROP trades at 381.0× earnings, expensive versus the ~22× long-run Nifty average.
What is the BAYERCROP share price target for 2031?
BAYERCROP's probability-weighted 2031 median target is ₹5,316, with an 80% range of ₹2,435-₹11,606 (10,000-path Monte-Carlo).
What is the probability BAYERCROP doubles in 5 years?
The modelled probability of BAYERCROP reaching ₹8,354 (2×) within 5 years is 23%.
What is the bull case for BAYERCROP?
BAYERCROP's return on equity of 15.8% ranks in the 74th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. BAYERCROP's return on capital employed of 20.1% ranks in the 80th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. BAYERCROP's dividend yield of 3.6% ranks in the top 3% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in BAYERCROP?
BAYERCROP's P/E of 381.0x is lower than 3% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A steep 49.4× price-to-book means most of the value is intangible/expectations, not assets on the books.